Re:Cabazitaxel Versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
- PMID: 32029338
- DOI: 10.1016/j.eururo.2020.01.018
Re:Cabazitaxel Versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
Comment on
-
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.N Engl J Med. 2019 Dec 26;381(26):2506-2518. doi: 10.1056/NEJMoa1911206. Epub 2019 Sep 30. N Engl J Med. 2019. PMID: 31566937 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical